4 hours Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of “Buy” by Analysts MarketBeat
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been given an average rating of “Buy” by the eight brokerages that are covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy r…